Company / Shares Outstanding
BioNexus Gene Lab Corp Shares Outstanding History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.8M
FY2025
5-year range
1.8M / 171.2M
FY2021-FY2025
Trend
-89.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 14476513.00 to 1796766.00 over the past 2 years.
Based on SEC 10-K filings.
1796766.00 in FY2025 with a 5-year CAGR of -55.5%.
Improved from 14476513.00 to 1796766.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -78.1%
- 5-Year CAGR
- -55.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding decreased 89.8% year-over-year.
- Peak shares outstanding was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.8M | -89.8% |
| FY2024 | 17.7M | +22.0% |
| FY2023 | 14.5M | -91.5% |
| FY2022 | 171.2M | +0.0% |
| FY2021 | 171.2M | +66.7% |
| FY2020 | 102.7M | +37.7% |
| FY2019 | 74.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026